NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 96 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $292,496 | -52.3% | 273,361 | +15.5% | 0.00% | – |
| Q2 2023 | $613,147 | -21.2% | 236,736 | +24.1% | 0.00% | – |
| Q1 2023 | $778,476 | -59.2% | 190,803 | -49.7% | 0.00% | – |
| Q4 2022 | $1,905,883 | -56.3% | 379,658 | +13.8% | 0.00% | -100.0% |
| Q3 2022 | $4,364,000 | +97.6% | 333,639 | +93.7% | 0.00% | – |
| Q2 2022 | $2,208,000 | -11.7% | 172,206 | +5.1% | 0.00% | -100.0% |
| Q1 2022 | $2,500,000 | -31.7% | 163,918 | -20.7% | 0.00% | 0.0% |
| Q4 2021 | $3,663,000 | -30.7% | 206,814 | -17.8% | 0.00% | 0.0% |
| Q3 2021 | $5,286,000 | +363.7% | 251,485 | +334.9% | 0.00% | – |
| Q2 2021 | $1,140,000 | -23.7% | 57,823 | +12.5% | 0.00% | – |
| Q1 2021 | $1,494,000 | +2.8% | 51,381 | +7.0% | 0.00% | – |
| Q4 2020 | $1,454,000 | +72.1% | 48,025 | -9.6% | 0.00% | – |
| Q3 2020 | $845,000 | -29.2% | 53,122 | -12.0% | 0.00% | – |
| Q2 2020 | $1,193,000 | +117.3% | 60,396 | +35.6% | 0.00% | – |
| Q1 2020 | $549,000 | -65.7% | 44,533 | -48.5% | 0.00% | – |
| Q4 2019 | $1,600,000 | +111.9% | 86,519 | +58.7% | 0.00% | – |
| Q3 2019 | $755,000 | -8.3% | 54,512 | -3.0% | 0.00% | – |
| Q2 2019 | $823,000 | – | 56,203 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,766,666 | $79,175,000 | 44.14% |
| Ponoi II Management, LLC | 1,298,908 | $27,303,000 | 40.46% |
| Column Group LLC | 15,396,116 | $323,626,000 | 36.81% |
| Ponoi Management, LLC | 1,298,908 | $27,303,000 | 24.24% |
| Euclidean Capital LLC | 832,274 | $17,494,000 | 8.50% |
| StepStone Group LP | 1,573,357 | $33,072,000 | 2.14% |
| Octagon Capital Advisors LP | 200,000 | $4,204,000 | 1.04% |
| Redmile Group, LLC | 2,505,118 | $52,658,000 | 0.92% |
| BVF INC/IL | 955,000 | $20,074,000 | 0.78% |
| Boxer Capital, LLC | 500,000 | $10,510,000 | 0.37% |